Literature DB >> 7142022

The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A.

U Weiss, K Yoshihira, R J Highet, R J White, T T Wei.   

Abstract

The yellow antibiotic chrysomycin, isolated in crystalline form in 1955, is found to consist of two closely related components, a major one, chrysomycin A, and a minor one, chrysomycin B. They differ only through the replacement of a vinyl group of chrysomycin A by methyl in chrysomycin B. The absorption spectrum of chrysomycin A is identical with that of the antitumor antibiotic toromycin (gilvocarcin V, 2064A), while that of chrysomycin B is similarly identical with the one of gilvocarcin M (2064B). The structures of these antibiotics (toromycin, the glivocarcins, and 2064A and B) have been elucidated recently. Chrysomycins A and B thus contain the same chromophores as gilvocarcins V and M, respectively; comparison of 1H and 13C NMR spectra confirms this identity. The chrysomycins differ from these other antibiotics in the C-glycosidic side-chain, which is a methylpentose in the gilvocarcins, a 3,5-dimethylpentose in the chrysomycins. Structure and relative configuration of the latter are given. The biological activity and possible biosynthesis of the chrysomycins are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142022     DOI: 10.7164/antibiotics.35.1194

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  14 in total

1.  Engineered biosynthesis of gilvocarcin analogues with altered deoxyhexopyranose moieties.

Authors:  Micah D Shepherd; Tao Liu; Carmen Méndez; Jose A Salas; Jürgen Rohr
Journal:  Appl Environ Microbiol       Date:  2010-11-12       Impact factor: 4.792

2.  Characterization of the TDP-D-ravidosamine biosynthetic pathway: one-pot enzymatic synthesis of TDP-D-ravidosamine from thymidine-5-phosphate and glucose-1-phosphate.

Authors:  Madan K Kharel; Hui Lian; Jürgen Rohr
Journal:  Org Biomol Chem       Date:  2011-01-24       Impact factor: 3.876

Review 3.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

4.  Light-dependent activity of the antitumor antibiotics ravidomycin and desacetylravidomycin.

Authors:  M Greenstein; T Monji; R Yeung; W M Maiese; R J White
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Structures and biological activities of novel 4'-acetylated analogs of chrysomycins A and B.

Authors:  Shun-Ichi Wada; Ryuichi Sawa; Fumiki Iwanami; Miho Nagayoshi; Yumiko Kubota; Kiyoko Iijima; Chigusa Hayashi; Yuko Shibuya; Masaki Hatano; Masayuki Igarashi; Manabu Kawada
Journal:  J Antibiot (Tokyo)       Date:  2017-09-06       Impact factor: 2.649

6.  Cloning and characterization of the ravidomycin and chrysomycin biosynthetic gene clusters.

Authors:  Madan K Kharel; S Eric Nybo; Micah D Shepherd; Jürgen Rohr
Journal:  Chembiochem       Date:  2010-03-01       Impact factor: 3.164

Review 7.  Delineation of gilvocarcin, jadomycin, and landomycin pathways through combinatorial biosynthetic enzymology.

Authors:  Madan K Kharel; Jürgen Rohr
Journal:  Curr Opin Chem Biol       Date:  2012-03-30       Impact factor: 8.822

8.  Enzymatic total synthesis of defucogilvocarcin M and its implications for gilvocarcin biosynthesis.

Authors:  Pallab Pahari; Madan K Kharel; Micah D Shepherd; Steven G van Lanen; Jürgen Rohr
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-23       Impact factor: 15.336

9.  Rh(iii)-catalyzed synthesis of dibenzo[b,d]pyran-6-ones from aryl ketone O-acetyl oximes and quinones via C-H activation and C-C bond cleavage.

Authors:  Wei Yang; Haonan Zhang; Yu Liu; Cuiman Tang; Xiaohui Xu; Jiaqi Liu
Journal:  RSC Adv       Date:  2022-05-12       Impact factor: 4.036

10.  Inactivation of the ketoreductase gilU gene of the gilvocarcin biosynthetic gene cluster yields new analogues with partly improved biological activity.

Authors:  Tao Liu; Madan K Kharel; Lili Zhu; Samuel A Bright; Cynthia Mattingly; Val R Adams; Jürgen Rohr
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.